239 related articles for article (PubMed ID: 28119099)
21. Picrasma quassiodes (D. Don) Benn. attenuates lipopolysaccharide (LPS)-induced acute lung injury.
Lee JW; Park JW; Shin NR; Park SY; Kwon OK; Park HA; Lim Y; Ryu HW; Yuk HJ; Kim JH; Oh SR; Ahn KS
Int J Mol Med; 2016 Sep; 38(3):834-44. PubMed ID: 27431288
[TBL] [Abstract][Full Text] [Related]
22. Phillyrin attenuates LPS-induced pulmonary inflammation via suppression of MAPK and NF-κB activation in acute lung injury mice.
Zhong WT; Wu YC; Xie XX; Zhou X; Wei MM; Soromou LW; Ci XX; Wang DC
Fitoterapia; 2013 Oct; 90():132-9. PubMed ID: 23751215
[TBL] [Abstract][Full Text] [Related]
23. Angelicin regulates LPS-induced inflammation via inhibiting MAPK/NF-κB pathways.
Liu F; Sun GQ; Gao HY; Li RS; Soromou LW; Chen N; Deng YH; Feng HH
J Surg Res; 2013 Nov; 185(1):300-9. PubMed ID: 23816246
[TBL] [Abstract][Full Text] [Related]
24. Isovitexin Exerts Anti-Inflammatory and Anti-Oxidant Activities on Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting MAPK and NF-κB and Activating HO-1/Nrf2 Pathways.
Lv H; Yu Z; Zheng Y; Wang L; Qin X; Cheng G; Ci X
Int J Biol Sci; 2016; 12(1):72-86. PubMed ID: 26722219
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of PKR ameliorates lipopolysaccharide-induced acute lung injury by suppressing NF-κB pathway in mice.
Li Y; Xiao J; Tan Y; Wang J; Zhang Y; Deng X; Luo Y
Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):165-172. PubMed ID: 28511573
[TBL] [Abstract][Full Text] [Related]
26.
Ma Q; Wang K; Yang Q; Ping S; Zhao W; Shou Q; Zhou W; Chen M
Mediators Inflamm; 2016; 2016():7934049. PubMed ID: 27890971
[No Abstract] [Full Text] [Related]
27. Therapeutic effect of methyl salicylate 2-O-β-d-lactoside on LPS-induced acute lung injury by inhibiting TAK1/NF-kappaB phosphorylation and NLRP3 expression.
Yang S; Yu Z; Yuan T; Wang L; Wang X; Yang H; Sun L; Wang Y; Du G
Int Immunopharmacol; 2016 Nov; 40():219-228. PubMed ID: 27620503
[TBL] [Abstract][Full Text] [Related]
28. Esculetin Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Mice Via Modulation of the AKT/ERK/NF-κB and RORγt/IL-17 Pathways.
Lee HC; Liu FC; Tsai CN; Chou AH; Liao CC; Yu HP
Inflammation; 2020 Jun; 43(3):962-974. PubMed ID: 32170603
[TBL] [Abstract][Full Text] [Related]
29. Zingerone attenuates lipopolysaccharide-induced acute lung injury in mice.
Xie X; Sun S; Zhong W; Soromou LW; Zhou X; Wei M; Ren Y; Ding Y
Int Immunopharmacol; 2014 Mar; 19(1):103-9. PubMed ID: 24412620
[TBL] [Abstract][Full Text] [Related]
30. Compound edaravone alleviates lipopolysaccharide (LPS)-induced acute lung injury in mice.
Zhang Z; Luo Z; Bi A; Yang W; An W; Dong X; Chen R; Yang S; Tang H; Han X; Luo L
Eur J Pharmacol; 2017 Sep; 811():1-11. PubMed ID: 28552343
[TBL] [Abstract][Full Text] [Related]
31. Euphorbia factor L2 alleviates lipopolysaccharide-induced acute lung injury and inflammation in mice through the suppression of NF-κB activation.
Zhang Q; Zhu S; Cheng X; Lu C; Tao W; Zhang Y; William BC; Cao X; Yi S; Liu Y; Zhao Y; Luo Y
Biochem Pharmacol; 2018 Sep; 155():444-454. PubMed ID: 30055150
[TBL] [Abstract][Full Text] [Related]
32. Shikonin exerts anti-inflammatory effects in a murine model of lipopolysaccharide-induced acute lung injury by inhibiting the nuclear factor-kappaB signaling pathway.
Liang D; Sun Y; Shen Y; Li F; Song X; Zhou E; Zhao F; Liu Z; Fu Y; Guo M; Zhang N; Yang Z; Cao Y
Int Immunopharmacol; 2013 Aug; 16(4):475-80. PubMed ID: 23651796
[TBL] [Abstract][Full Text] [Related]
33. Dehydrocostus Lactone Suppresses LPS-induced Acute Lung Injury and Macrophage Activation through NF-κB Signaling Pathway Mediated by p38 MAPK and Akt.
Nie Y; Wang Z; Chai G; Xiong Y; Li B; Zhang H; Xin R; Qian X; Tang Z; Wu J; Zhao P
Molecules; 2019 Apr; 24(8):. PubMed ID: 30999647
[TBL] [Abstract][Full Text] [Related]
34. Effects of resolvin D1 on inflammatory responses and oxidative stress of lipopolysaccharide-induced acute lung injury in mice.
Wang L; Yuan R; Yao C; Wu Q; Christelle M; Xie W; Zhang X; Sun W; Wang H; Yao S
Chin Med J (Engl); 2014; 127(5):803-9. PubMed ID: 24571866
[TBL] [Abstract][Full Text] [Related]
35. p38 Mitogen-activated protein kinase up-regulates LPS-induced NF-kappaB activation in the development of lung injury and RAW 264.7 macrophages.
Kim HJ; Lee HS; Chong YH; Kang JL
Toxicology; 2006 Aug; 225(1):36-47. PubMed ID: 16793190
[TBL] [Abstract][Full Text] [Related]
36. Total flavonoids of Mosla scabra leaves attenuates lipopolysaccharide-induced acute lung injury via down-regulation of inflammatory signaling in mice.
Chen J; Wang JB; Yu CH; Chen LQ; Xu P; Yu WY
J Ethnopharmacol; 2013 Jul; 148(3):835-41. PubMed ID: 23747643
[TBL] [Abstract][Full Text] [Related]
37. Protective effect of esculentoside A on lipopolysaccharide-induced acute lung injury in mice.
Zhong WT; Jiang LX; Wei JY; Qiao AN; Wei MM; Soromou LW; Xie XX; Zhou X; Ci XX; Wang DC
J Surg Res; 2013 Nov; 185(1):364-72. PubMed ID: 23764313
[TBL] [Abstract][Full Text] [Related]
38. Fraxin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting the NF-κB and NLRP3 signalling pathways.
Li W; Li W; Zang L; Liu F; Yao Q; Zhao J; Zhi W; Niu X
Int Immunopharmacol; 2019 Feb; 67():1-12. PubMed ID: 30530164
[TBL] [Abstract][Full Text] [Related]
39. Protective effect of pteryxin on LPS-induced acute lung injury via modulating MAPK/NF-κB pathway and NLRP3 inflammasome activation.
Xuan TQ; Gong G; Du H; Liu C; Wu Y; Bao G; Ma Q; Zhen D
J Ethnopharmacol; 2022 Mar; 286():114924. PubMed ID: 34942323
[TBL] [Abstract][Full Text] [Related]
40. Pretreatment with the compound asperuloside decreases acute lung injury via inhibiting MAPK and NF-κB signaling in a murine model.
Qiu J; Chi G; Wu Q; Ren Y; Chen C; Feng H
Int Immunopharmacol; 2016 Feb; 31():109-15. PubMed ID: 26710167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
